newsfilter
← Latest News
GlobeNewswire·

Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering

CHAPEL HILL, N.C., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (NASDAQ:TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address